Pii, a Jabil company, is a contract development and manufacturing organization (CDMO) specializing in complex oral formulations. From its Hunt Valley, Maryland campus, Pii develops and manufactures tablets, capsules, softgels and oral liquids, including highly potent and DEA-controlled compounds, taking programs from first clinical batch to commercial supply on one site. State-of-the-art analytical and R&D laboratories support every program from formulation through release. Pii also offers aseptic manufacturing and sterile fill-finish. Combining more than 30 years of formulation expertise with Jabil’s global supply chain and operational excellence, Pii delivers big-company capability with the attention every program deserves.

Learn more at pharm-int.com.